Key result
The high-molecular weight adiponectin ratio (HMWR) was a better predictor of insulin resistance than total adiponectin, with a significantly larger AUC (0.713 vs 0.615; P=0.0160).
Why the study?
Does the HMW adiponectin ratio improve the prediction of insulin resistance and metabolic syndrome compared to total adiponectin levels in patients admitted for diabetes treatment or coronary angiography?
Observational (n=298)
Does the HMW adiponectin ratio improve the prediction of insulin resistance and metabolic syndrome compared to total adiponectin levels in patients admitted for diabetes treatment or coronary angiography?
Absolute Event Rate: 0.713% vs 0.615%
p-value: p=0.0160
The ratio of high-molecular weight to total adiponectin is a superior biomarker compared to total adiponectin alone for identifying insulin resistance and metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
HMWR may outperform total adiponectin for insulin resistance prediction; leaves open its utility for metabolic syndrome screening in diabetes or CAD admissions.
Hara et al. (2006) conducted an observational in Diabetes or coronary artery disease (n=298). High-molecular weight adiponectin ratio (HMWR) vs. Plasma total adiponectin was evaluated on Prediction of insulin resistance (AUC) (95% CI 0.620-0.805, p=0.0160). The high-molecular weight adiponectin ratio (HMWR) was a better predictor of insulin resistance than total adiponectin, with a significantly larger AUC (0.713 vs 0.615; P=0.0160).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: